Top news of the week: 26.10.2023.
Thermo Fisher's warning on more pain from biotech funding squeeze hits sector
Thermo Fisher's warning on more pain from biotech funding squeeze hits sector
A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
Pfizer will still benefit from the 25% stake it retained as well as full rights to the drug outside the US and Japan.
Gut Feeling: Bowel Disease Drugmaker Abivax Uplists from Paris to Nasdaq
October 19, 2023 Investors with an appetite for bowel disease biotech have a new European deal to digest.
English phage project gets funding boost
Work in England to develop bacteriophages to tackle disease has received funding support. The £800,000 ($975,000) grant from the Biotechnology and
These Gene-Editing Stocks Are Survivors. Take Another Look.
The market has nearly abandoned many of the biotech start-ups it funded in the excitement of the first Covid vaccines in 2021, leaving the pioneers of an elegant approach to …
Centre of Excellence at IIT Madras to develop biomarkers for early detection of pancreatic cancer
The Indian Institute of Technology (IIT), Madras has set up a Centre of Excellence to develop biomarkers for early detection of pancreatic cancer. The centre aims to create an ...
A web-based platform for the annotation and analysis of NAR-published databases
Biological databases are essential resources for life science research, but finding and selecting the most relevant and up-to-date databases can be challenging due to the large number and ...
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study
Objective We sought to evaluate the variability of HIV-1 and its effect on immuno-virological response among adolescents living with perinatally acquired HIV (APHI). Methods A cohort ...